Cavan, Mary Joy B.
HRN: 03-51-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2026
MUPIROCIN 2%, 15G (TUBE)
07/29/2026
08/04/2026
DERMAL
2%
OD
Sp 1 LTCS
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: